NO20003640L - Ny doseringsform - Google Patents

Ny doseringsform

Info

Publication number
NO20003640L
NO20003640L NO20003640A NO20003640A NO20003640L NO 20003640 L NO20003640 L NO 20003640L NO 20003640 A NO20003640 A NO 20003640A NO 20003640 A NO20003640 A NO 20003640A NO 20003640 L NO20003640 L NO 20003640L
Authority
NO
Norway
Prior art keywords
administered
dosage unit
food
outer coating
pharmaceutical
Prior art date
Application number
NO20003640A
Other languages
English (en)
Other versions
NO20003640D0 (no
Inventor
Peter Watts
Lisbeth Illum
Original Assignee
West Pharmaceutical Service Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharmaceutical Service Dr filed Critical West Pharmaceutical Service Dr
Publication of NO20003640D0 publication Critical patent/NO20003640D0/no
Publication of NO20003640L publication Critical patent/NO20003640L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Abstract

Dose-enhet med størrelse større enn 7 mm, som kan administreres oralt, omfattende et medikament og et ytre belegg som er utformet for å hindre frigivelse av medika- mentet i magen eller tynn-tarmen når den farmasøytiske dose-enheten er i nærvær av mat. Foreliggende oppfinnelse framskaffer videre en dose-enhet med størrelse større enn 7 mm, som kan administreres oralt, omfattende et medika- ment og et ytre belegg, hvor belegget er laget av et materiale som er løselig ved pH-verdier under 5,0 og egnet for å skille den farmasøytiske dose-enheten fra sam- administrert mat. Den farmasøytiske dose-enheten er fortrinnsvis i form av en belagt tablett eller kapsel. Det er fordelaktig om det ytre belegget er en polymer. I tillegg angår foreliggende oppfinnelse en framgangsmåte for å separere oralt administrerte dose-enheter fra sam- administrert mat, og bruk av nevnte farmasøytiske dose- enheter innen medisin.
NO20003640A 1998-01-22 2000-07-14 Ny doseringsform NO20003640L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9801363.4A GB9801363D0 (en) 1998-01-22 1998-01-22 Novel dosage form
PCT/GB1999/000193 WO1999037290A1 (en) 1998-01-22 1999-01-20 Novel dosage form

Publications (2)

Publication Number Publication Date
NO20003640D0 NO20003640D0 (no) 2000-07-14
NO20003640L true NO20003640L (no) 2000-09-12

Family

ID=10825713

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003640A NO20003640L (no) 1998-01-22 2000-07-14 Ny doseringsform

Country Status (9)

Country Link
EP (1) EP1059918A1 (no)
JP (1) JP2002501016A (no)
AR (1) AR014467A1 (no)
AU (1) AU2176099A (no)
CA (1) CA2318257A1 (no)
GB (1) GB9801363D0 (no)
NO (1) NO20003640L (no)
WO (1) WO1999037290A1 (no)
ZA (1) ZA99454B (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
WO2006020009A1 (en) * 2004-07-23 2006-02-23 The Procter & Gamble Company Solid oral dosage form of a bisphosphonate containing a chelating agent
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
CN101496042A (zh) 2006-05-02 2009-07-29 普罗秋斯生物医学公司 患者定制的治疗方案
EP2083680B1 (en) 2006-10-25 2016-08-10 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
ES2930588T3 (es) 2007-02-01 2022-12-19 Otsuka Pharma Co Ltd Sistemas de marcador de eventos ingeribles
KR101528748B1 (ko) 2007-02-14 2015-06-15 프로테우스 디지털 헬스, 인코포레이티드 고 표면적 전극을 갖는 체내 전원
EP2124725A1 (en) 2007-03-09 2009-12-02 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
DK2192946T3 (da) 2007-09-25 2022-11-21 Otsuka Pharma Co Ltd Kropsintern anordning med virtuel dipol signalforstærkning
SG190590A1 (en) 2007-11-27 2013-06-28 Proteus Digital Health Inc Transbody communication systems employing communication channels
ES2840773T3 (es) 2008-03-05 2021-07-07 Otsuka Pharma Co Ltd Sistemas y marcadores de eventos ingeribles de comunicación multimodo
SG195535A1 (en) 2008-07-08 2013-12-30 Proteus Digital Health Inc Ingestible event marker data framework
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
JP2012514799A (ja) 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド 摂取に関連するバイオフィードバックおよび個別薬物療法の方法およびシステム
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
WO2010129288A2 (en) 2009-04-28 2010-11-11 Proteus Biomedical, Inc. Highly reliable ingestible event markers and methods for using the same
WO2010132331A2 (en) 2009-05-12 2010-11-18 Proteus Biomedical, Inc. Ingestible event markers comprising an ingestible component
TWI517050B (zh) 2009-11-04 2016-01-11 普羅托斯數位健康公司 供應鏈管理之系統
AU2011237612B2 (en) * 2010-04-07 2016-05-12 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
TWI557672B (zh) 2010-05-19 2016-11-11 波提亞斯數位康健公司 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
WO2012071280A2 (en) 2010-11-22 2012-05-31 Proteus Biomedical, Inc. Ingestible device with pharmaceutical product
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
MX340001B (es) 2011-07-21 2016-06-20 Proteus Digital Health Inc Dispositivo, sistema y método de comunicación móvil.
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
RU2015105699A (ru) 2012-07-23 2016-09-10 Протеус Диджитал Хелс, Инк. Способы получения проглатываемых маркеров событий, содержащих проглатываемый компонент
JP5869736B2 (ja) 2012-10-18 2016-02-24 プロテウス デジタル ヘルス， インコーポレイテッド 通信デバイス用の電源において電力消失およびブロードキャスト電力を適応的に最適化するための装置、システム、および方法
TWI659994B (zh) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 高度可膨脹之聚合型薄膜及包含彼之組成物
JP5941240B2 (ja) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス， インコーポレイテッド 金属検出器装置、システム、および方法
EP3005281A4 (en) 2013-06-04 2017-06-28 Proteus Digital Health, Inc. System, apparatus and methods for data collection and assessing outcomes
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
BR112019000861B1 (pt) 2016-07-22 2020-10-27 Proteus Digital Health, Inc dispositivo eletrônico
CA3041041A1 (en) 2016-10-26 2018-05-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers
US11458104B1 (en) * 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN109453166B (zh) * 2018-10-16 2021-03-12 丹诺医药(苏州）有限公司 一种利福霉素-喹嗪酮偶联分子的固体分散体及其应用
CN110613697A (zh) * 2019-10-30 2019-12-27 长春迪瑞制药有限公司 一种头孢氨苄胶囊及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
NZ228557A (en) * 1988-04-05 1990-11-27 Kyowa Hakko Kogyo Kk Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions

Also Published As

Publication number Publication date
EP1059918A1 (en) 2000-12-20
ZA99454B (en) 2000-10-23
AR014467A1 (es) 2001-02-28
NO20003640D0 (no) 2000-07-14
AU2176099A (en) 1999-08-09
WO1999037290A1 (en) 1999-07-29
CA2318257A1 (en) 1999-07-29
GB9801363D0 (en) 1998-03-18
JP2002501016A (ja) 2002-01-15

Similar Documents

Publication Publication Date Title
NO20003640L (no) Ny doseringsform
RU2404750C2 (ru) Композиция, содержащая основу или покрытие для замедленного высвобождения и антагонист nmda рецептора, способ введения такого nmda антагониста субъекту
FI113336B (fi) Menetelmä tramadolisuolaa sisältävän lääkeaineen valmistamiseksi, jolla on viivästynyt vaikuttavan aineen vapautuminen
EP1595538A3 (en) Modified release tamsulosin tablets
CA2144094A1 (en) Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
AU4334700A (en) Pharmaceutical dosage form for pulsatile delivery of methylphenidate
JP3633936B2 (ja) センナ剤形
BG104317A (en) Method for the treatment of capsules and dry, powder pharmaceutical forms
TWI241195B (en) Preventive agent for bile acidic diarrhea
HUP0001382A2 (hu) Eritromicinszármazékokat tartalmazó, ezek késleltetett felszabadulását biztosító készítmények
JP2006016395A (ja) 薬物依存の処置に使用する薬物の安全な投与用の薬学的処方及び薬学的処方の取得方法
MX9500885A (es) Preparacion farmaceutica para administracion oral.
AU1227899A (en) Osmotic medicament releasing system
CA2601289A1 (en) Once-a-day oxycodone formulations
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
TW200418484A (en) Novel formulations and method of treatment
EP1217992A1 (en) Coated solid dosage forms
SA520411808B1 (ar) أقراص ديفيريبرون مؤخرة الإطلاق وطرق لاستخدامها
Namdev et al. Floating Drug Delivery Systems: An emerging trend for the treatment of peptic ulcer
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
MY137516A (en) Pharmaceutical composition comprising lumiracoxib
FI89238B (fi) Foerfarande foer framstaellning av kompressionsbelagda tabletter
DK165123B (da) Fremgangsmaade til mekanisk bearbejdning af cobalt-holdige metaller samt med vand blandbart koncentrat til brug ved fremgangsmaaden
RU2000114174A (ru) Применение фосфолипидных комплексов экстрактов из vitis vinifera в качестве противоатеросклеротических агентов
US5082665A (en) Anti-snoring formulations using yohimbine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application